Key result
Cyproheptadine and supportive measures aid ~3-week recovery from overlapping serotonin and neuroleptic malignant syndromes.
Why the study?
Serotonin syndrome and neuroleptic malignant syndrome have overlapping and confusing clinical presentations that complicate diagnosis and management.
Case Report (n=1)
This case highlights the possibility of concurrent serotonin syndrome and neuroleptic malignant syndrome, emphasizing the need for careful clinical evaluation to distinguish and manage these overlapping toxidromes.
No takes yet. Share an insight, caveat, or question.
Overlapping serotonin syndrome and neuroleptic malignant syndrome may respond to cyproheptadine; single case leaves open optimal management strategies.
Dosi et al. (2014) conducted a case report in Serotonin syndrome and neuroleptic malignant syndrome (n=1). Cyproheptadine and supportive measures was evaluated on Recovery. A young man with overlapping serotonin syndrome and neuroleptic malignant syndrome recovered over 3 weeks with cyproheptadine and supportive measures.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: